Join
Live feed
·
INSIDERFilingvia Quantisnow
Zymeworks Inc. logo

EVP & Chief Medical Officer Smith Jeffrey T L sold $264,471 worth of shares (10,538 units at $25.10) and converted options into 20,000 shares, increasing direct ownership by 106% to 18,352 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ZYME· Zymeworks Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYME (Zymeworks Inc.) and more on Quantisnow.

EVP & Chief Medical Officer Smith Jeffrey T L sold $264,471 worth of shares (10,538 units at $25.10) and converted options into 20,000 shares, increasing direct ownership by 106% to 18,352 units (SEC Form 4) | Quantisnow